Showing results (61-70 of 402) with videos related to

Sort By:
Pageof 41
European Journal of Clinical Investigation|September 7, 2020
Pre-treatment high-sensitivity troponin T for the short-term prediction of cardiac outcomes in patients on immune checkpoint inhibitorsSerena Petricciuolo, Maria Grazia Delle Donne, Alberto Aimo, et al.
European Journal of Clinical Investigation|November 30, 2020
Effect of low-dose colchicine in acute and chronic coronary syndromes: A systematic review and meta-analysisAlberto Aimo, Domingo A Pascual Figal, Antoni Bayes-Genis, et al.
Frontiers in Cardiovascular Medicine|August 27, 2021
COVID-19 and Heart Failure: From Epidemiology During the Pandemic to Myocardial Injury, Myocarditis, and Heart Failure SequelaeLeonardo Italia, Daniela Tomasoni, Stefano Bisegna, et al.
Heart Failure Reviews|June 24, 2020
Cardiovascular magnetic resonance for the diagnosis and management of heart failure with preserved ejection fractionAndrea Barison, Alberto Aimo, Giancarlo Todiere, et al.
ESC Heart Failure|June 11, 2026
Event rates in major Phase 3 heart failure trials over the last 20 yearsAlberto Aimo, Giorgia Panichella, Andrea Ripoli, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|November 2, 2020
Imaging predictors of incident heart failure: a systematic review and meta-analysisGeorgios Georgiopoulos, Alberto Aimo, Andrea Barison, et al.
Minerva Cardiology and Angiology|April 12, 2022
The revolution of ATTR amyloidosis in cardiology: certainties, gray zones and perspectivesClaudio Rapezzi, Giuseppe Vergaro, Michele Emdin, et al.
International Journal of Cardiology|May 26, 2018
The IL-33/ST2 pathway, inflammation and atherosclerosis: Trigger and target?Alberto Aimo, Paola Migliorini, Giuseppe Vergaro, et al.
European Journal of Preventive Cardiology|March 24, 2018
N-terminal fraction of pro-B-type natriuretic peptide versus clinical risk scores for prognostic stratification in chronic systolic heart failureChiara Arzilli, Alberto Aimo, Giuseppe Vergaro, et al.
Heart Failure Reviews|October 11, 2022
Treatment of cardiac fibrosis: from neuro-hormonal inhibitors to CAR-T cell therapyPaolo Morfino, Alberto Aimo, Vincenzo Castiglione, et al.
Pageof 41